MCRB financials

Seres Therapeutics (MCRB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

MCRB income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$789.00K–-$93.97M$5.70M0.64
2024$0.00–-$121.31M$136.00K0.00
2023$0.00–-$195.10M-$113.72M-17.77
2022$7.13M–-$179.91M-$250.16M-46.20
2021$144.93M–-$64.49M-$65.58M-14.40
2020$33.22M–-$88.13M-$89.13M-22.40